Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Residual respiratory impairment after COVID-19 pneumonia.
BMC Pulm Med. 2021 Jul 17;21(1):241. doi: 10.1186/s12890-021-01594-4.
BMC Pulm Med. 2021.
PMID: 34273962
Free PMC article.
COVID-related fibrosis: insights into potential drug targets.
Sgalla G, Comes A, Lerede M, Richeldi L.
Sgalla G, et al. Among authors: lerede m.
Expert Opin Investig Drugs. 2021 Dec;30(12):1183-1195. doi: 10.1080/13543784.2021.2010188. Epub 2021 Dec 1.
Expert Opin Investig Drugs. 2021.
PMID: 34842488
Review.
Item in Clipboard
Emerging drugs for the treatment of idiopathic pulmonary fibrosis: 2020 phase II clinical trials.
Sgalla G, Lerede M, Richeldi L.
Sgalla G, et al. Among authors: lerede m.
Expert Opin Emerg Drugs. 2021 Jun;26(2):93-101. doi: 10.1080/14728214.2021.1931119. Epub 2021 May 24.
Expert Opin Emerg Drugs. 2021.
PMID: 33998354
Review.
Item in Clipboard
COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis.
Sgalla G, Magrì T, Lerede M, Comes A, Richeldi L.
Sgalla G, et al. Among authors: lerede m.
Am J Respir Crit Care Med. 2022 Jul 15;206(2):219-221. doi: 10.1164/rccm.202112-2765LE.
Am J Respir Crit Care Med. 2022.
PMID: 35412453
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite